The University of North Carolina at Chapel Hill is a public research university in Chapel Hill, North Carolina. The flagship of the University of North Carolina system, it is considered a Public Ivy, or a public institution which offers an academic experience similar to that of an Ivy League university.

During the past decade, University of North Carolina at Chapel Hill conducted 902 clinical trials. In the 10-year time frame, 902 clinical trials started and 531 clinical trials were completed, i.e. on average, 58.9% percent of trials that started reached the finish line to date. In the past 5 years, 381 clinical trials started and 291 clinical trials were completed. i.e. 76.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of North Carolina at Chapel Hill" #1 sponsor was "University of North Carolina, Chapel Hill" with 429 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 84 trials sponsored, "UNC Lineberger Comprehensive Cancer Center" with 60 trials sponsored, "Duke University" with 33 trials sponsored and "Bristol-Myers Squibb" with 33 trials sponsored. Other sponsors include 1070 different institutions and companies that sponsored additional 490 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of North Carolina at Chapel Hill" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 76 trials as a collaborator, "National Cancer Institute (NCI)" with 73 trials as a collaborator, "University of North Carolina, Chapel Hill" with 60 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 56 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 52 trials as a collaborator. Other collaborators include 1580 different institutions and companies that were collaborators in the rest 669 trials.

According to Clinical.Site data, the most researched conditions in "University of North Carolina at Chapel Hill" are "HIV Infections" (102 trials), "Cystic Fibrosis" (44 trials), "Breast Cancer" (41 trials), "Obesity" (25 trials) and "Colorectal Cancer" (22 trials). Many other conditions were trialed in "University of North Carolina at Chapel Hill" in a lesser frequency.

Most popular intervention types in "University of North Carolina at Chapel Hill" are "Drug" (862 trials), "Other" (259 trials), "Behavioral" (202 trials), "Device" (195 trials) and "Biological" (130 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (206 trials), "Zidovudine" (24 trials), "Paclitaxel" (19 trials), "Carboplatin" (17 trials) and "Cyclophosphamide" (16 trials). Other intervention names were less common.

The vast majority of trials in "University of North Carolina at Chapel Hill" are 1448 trials for "All" genders, 203 trials for "Female" genders and 58 trials for "Male" genders.

Currently, there are 422 active trials in "University of North Carolina at Chapel Hill". 9 are not yet recruiting, 239 are recruiting, 151 are Active, not recruiting, and 23 are Enrolling by invitation. In total, there were 1083 completed trials in University of North Carolina at Chapel Hill, undefined suspended trials, and 150 terminated clinical trials to date.

Out of the total trials that were conducted in University of North Carolina at Chapel Hill, 168 "Phase 1" clinical trials were conducted, 431 "Phase 2" clinical trials and 340 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 62 trials, and there were also 468 trials that are defined as “Not Applicable".

University of North Carolina at Chapel Hill has several departments that took part in Clinical trials: "University of North Carolina School of Dentistry" - 32 trials, "University of North Carolina at Chapel Hill, Department of Radiation Oncology" - 17 trials, "UNC at Chapel Hill School of Medicine - Dept. of Peds., Div. of Immunology & Infectious Diseases" - 17 trials, "University of North Carolina AIDS Clinical Trials Unit" - 7 trials, "University of North Carolina, Department of Psychiatry" - 6 trials, "UNC Center for Functional GI & Motility Disorders" - 6 trials, "University of North Carolina, Dept of Ophthalmology" - 6 trials, "UNC Children's Research Institute" - 4 trials, "UNC Center for Health Promotion and Disease Prevention" - 4 trials, "University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology" - 4 trials, "UNC Department of Family Medicine" - 3 trials, "Department of Periodontology UNC School of Dentistry" - 3 trials, "North Carolina Jaycee Burn Center" - 3 trials, "University of North Carolina Center for Inflammatory Bowel Disease" - 3 trials, "UNC Comprehensive Sickle Cell Program" - 3 trials, "UNC Center of Excellence for Eating Disorders" - 3 trials, "UNC Dermatology Clinical Trials Unit" - 3 trials, "University of North Carolina Department of Dermatology" - 2 trials, "Psychiatry And Clinical Research" - 2 trials, "University of North Carolina-Chapel Hill MS Clinic Within the Neuroscience Hospital" - 2 trials, "University of North Carolina, Division of Genetics and Metabolism" - 2 trials, "University of North Carolina Chapel Hill Physician Office Building" - 2 trials, "University of North Carolina Chapel Hill STD Clinic" - 2 trials, "North Carolina Children's and Adults Clinical Research Foundation" - 2 trials, "UNC Department of Neurology, Physicians Office Building" - 2 trials